Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,456 | 72,000 | 167,000 | 300,000 | 596,000 |
| Depreciation Amortization | 125 | 823,000 | 624,000 | 424,000 | 211,000 |
| Income taxes - deferred | N/A | -610,000 | -330,000 | -329,000 | -313,000 |
| Accounts receivable | N/A | -47,000 | -20,000 | -13,000 | 24,000 |
| Accounts payable and accrued liabilities | 505 | N/A | N/A | N/A | N/A |
| Other Working Capital | 176 | 137,000 | 176,000 | 124,000 | 113,000 |
| Other Operating Activity | 830 | 210,000 | -116,000 | -276,000 | -482,000 |
| Operating Cash Flow | $-7,820 | $585,000 | $501,000 | $230,000 | $149,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -910 | 548,000 | 471,000 | -86,000 | -31,000 |
| Net Acquisitions | N/A | -3,319,000 | -3,249,000 | -3,263,000 | -3,263,000 |
| Other Investing Activity | 0 | 12,000 | 7,000 | 3,000 | 2,000 |
| Investing Cash Flow | $-910 | $-2,759,000 | $-2,771,000 | $-3,346,000 | $-3,292,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 1,743,000 | 1,747,000 | 425,000 | 425,000 |
| Debt Repayment | N/A | -2,589,000 | -2,261,000 | -331,000 | -299,000 |
| Common Stock Issued | N/A | 150,000 | 150,000 | 150,000 | 150,000 |
| Dividend Paid | N/A | -22,000 | -16,000 | -11,000 | -5,000 |
| Other Financing Activity | 19,989 | -581,000 | -575,000 | -508,000 | -499,000 |
| Financing Cash Flow | $19,989 | $-1,299,000 | $-955,000 | $-275,000 | $-228,000 |
| Beginning Cash Position | 6,508 | 3,838,000 | 3,838,000 | 3,838,000 | 3,838,000 |
| End Cash Position | 17,767 | 365,000 | 613,000 | 447,000 | 467,000 |
| Net Cash Flow | $11,259 | $-3,473,000 | $-3,225,000 | $-3,391,000 | $-3,371,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,820 | 585,000 | 501,000 | 230,000 | 149,000 |
| Capital Expenditure | -910 | -224,000 | -129,000 | -86,000 | -31,000 |
| Free Cash Flow | -8,730 | 361,000 | 372,000 | 144,000 | 118,000 |